| 사무소 | 담당자 | 전체 처수 | 평가 | 현황 (수치) | 현황 (%) · 금액 5 : 거래처 5 | 전월 주관 단계 | 전월 객관 단계 | 수립 목표 단계 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 종합 | 수립률 20% | 약속률 20% (금액/거래처) | 일치율 60% (금액/거래처) |
수립처 (적용/미적용) | MBO | 약속금액 | 확인금액 | 금액 약속률 | 거래처 약속률 (달성처/약속처) | 금액 일치율 | 거래처 일치율 (달성처/수립처) |
5단계 | 4단계 | 5단계 | 4단계 | 5단계 | 4단계 | |||
| 약국1팀 | 양지성 | 2,080 | C+ | S | B+ (S/D) | D (D/D) | 685 (685/2) | 614,300 | 616,300 | 242,046 | 254.6% | 5.4% (37/685) | 39.4% | 5.4% (37/685) | 49 | 418 | 77 | 80 | 231 | 454 |
| 약국2팀 | 이요한 | 1,760 | C+ | B+ | B+ (S/D) | D (D/D) | 461 (461/2) | 394,400 | 217,300 | 120,141 | 180.9% | 2.1% (5/233) | 30.5% | 5.0% (23/461) | 55 | 422 | 41 | 67 | 154 | 307 |
| 약국3팀 | 배재현 | 2,457 | C | B+ | D (D/D) | D (D/D) | 491 (491/0) | 507,400 | 131,500 | 206,216 | 63.8% | 8.6% (13/151) | 40.6% | 7.1% (35/491) | 55 | 640 | 99 | 99 | 168 | 323 |
| 약국4팀 | 임태균 | 1,515 | C+ | B+ | B+ (S/D) | D (D/D) | 299 (299/0) | 283,100 | 275,200 | 158,660 | 173.5% | 8.6% (25/291) | 56.0% | 8.7% (26/299) | 23 | 312 | 61 | 79 | 51 | 248 |
| 약국VC1팀 | 송하나 | 2,006 | C+ | A+ | B+ (S/D) | D (D/D) | 581 (581/2) | 545,500 | 385,600 | 143,033 | 269.6% | 2.7% (11/409) | 26.2% | 3.4% (20/581) | 81 | 219 | 50 | 62 | 175 | 406 |
| 약국VC2팀 | 최재건 | 3,096 | C | B+ | C+ (D/B+) | D (D/D) | 636 (636/4) | 953,220 | 9,847 | 316,250 | 3.1% | 73.9% (34/46) | 33.2% | 5.7% (36/636) | 103 | 515 | 107 | 121 | 200 | 436 |
| 약국VC3팀 | 김진홍 | 3,120 | C+ | A | B+ (S/D) | D (D/D) | 846 (846/0) | 738,700 | 593,600 | 368,305 | 161.2% | 9.3% (61/655) | 49.9% | 8.3% (70/846) | 138 | 970 | 134 | 120 | 276 | 570 |
| 약국VC4팀 | 김태환 | 938 | C+ | A | B (A/D) | D (D/D) | 285 (285/0) | 241,300 | 167,900 | 120,306 | 139.6% | 7.5% (7/93) | 49.9% | 7.0% (20/285) | 41 | 267 | 51 | 42 | 92 | 193 |
| 사업부 합계 | 김정한 | 16,972 | C+ | A | B (A+/D) | D (D/D) | 4,284 (4284/10) | 4,277,920 | 2,397,247 | 1,674,958 | 143.1% | 7.5% (193/2563) | 39.2% | 6.2% (267/4284) | 545 | 3763 | 620 | 670 | 1347 | 2937 |
| 사무소 | 담당자 | 전체 처수 | 평가 | 현황 (수치) | 현황 (%) · 금액 5 : 거래처 5 | 전월 주관 단계 | 전월 객관 단계 | 수립 목표 단계 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 종합 | 수립률 20% | 약속률 20% (금액/거래처) | 일치율 60% (금액/거래처) |
수립처 (적용/미적용) | MBO | 약속금액 | 확인금액 | 금액 약속률 | 거래처 약속률 (달성처/약속처) | 금액 일치율 | 거래처 일치율 (달성처/수립처) |
5단계 | 4단계 | 5단계 | 4단계 | 5단계 | 4단계 | |||
| 약국1팀 | 권동운 | 650 | C+ | S | B+ (S/D) | D (D/D) | 142 (142/0) | 123,300 | 123,300 | 69,947 | 176.3% | 9.9% (14/142) | 56.7% | 9.9% (14/142) | 13 | 62 | 13 | 18 | 49 | 93 |
| 약국1팀 | 김영수 | 347 | C+ | S | B+ (S/D) | D (D/D) | 138 (138/0) | 121,200 | 121,200 | 31,299 | 387.2% | 2.9% (4/138) | 25.8% | 2.9% (4/138) | 11 | 85 | 17 | 15 | 46 | 92 |
| 약국1팀 | 이규리 | 354 | C+ | A+ | B+ (S/D) | D (D/D) | 133 (133/2) | 100,000 | 102,000 | 48,822 | 208.9% | 7.5% (10/133) | 48.8% | 7.5% (10/133) | 6 | 88 | 16 | 14 | 44 | 89 |
| 약국1팀 | 이승식 | 361 | C+ | A+ | B+ (S/D) | D (D/D) | 135 (135/0) | 101,400 | 101,400 | 29,818 | 340.1% | 2.2% (3/135) | 29.4% | 2.2% (3/135) | 12 | 90 | 14 | 15 | 46 | 89 |
| 약국1팀 | 주세훈 | 368 | C+ | S | B+ (S/D) | D (D/D) | 137 (137/0) | 168,400 | 168,400 | 62,161 | 270.9% | 4.4% (6/137) | 36.9% | 4.4% (6/137) | 7 | 93 | 17 | 18 | 46 | 91 |
| 약국2팀 | 김종각 | 346 | D | D | D (D/D) | D (D/D) | 0 (0/0) | 0 | 0 | 0 | 0.0% | 0.0% (0/0) | 0.0% | 0.0% (0/0) | 1 | 94 | 8 | 14 | 0 | 0 |
| 약국2팀 | 박재만 | 353 | C+ | A+ | B+ (S/D) | D (D/D) | 116 (116/2) | 85,500 | 86,100 | 27,671 | 311.2% | 2.6% (3/116) | 32.4% | 2.6% (3/116) | 10 | 87 | 7 | 11 | 39 | 77 |
| 약국2팀 | 신천우 | 364 | C | A+ | D (D/D) | D (D/D) | 115 (115/0) | 91,200 | 0 | 32,667 | 0.0% | 0.0% (0/0) | 35.8% | 7.0% (8/115) | 5 | 90 | 7 | 11 | 39 | 76 |
| 약국2팀 | 안창현 | 348 | C+ | A+ | B+ (S/D) | D (D/D) | 115 (115/0) | 84,200 | 84,200 | 20,663 | 407.5% | 1.7% (2/115) | 24.5% | 1.7% (2/115) | 29 | 65 | 8 | 18 | 38 | 77 |
| 약국2팀 | 오종현 | 349 | C+ | A+ | C+ (B+/D) | D (D/D) | 115 (115/0) | 133,500 | 47,000 | 39,140 | 120.1% | 0.0% (0/2) | 29.3% | 8.7% (10/115) | 10 | 86 | 11 | 13 | 38 | 77 |
| 약국3팀 | 김기범 | 351 | C | A | D (D/D) | D (D/D) | 94 (94/0) | 71,400 | 0 | 28,791 | 0.0% | 0.0% (0/0) | 40.3% | 5.3% (5/94) | 7 | 92 | 13 | 10 | 30 | 64 |
| 약국3팀 | 김도엽 | 705 | C | B+ | D (D/D) | D (D/D) | 74 (74/0) | 142,400 | 0 | 66,702 | 0.0% | 0.0% (0/0) | 46.8% | 12.2% (9/74) | 17 | 180 | 30 | 32 | 32 | 42 |
| 약국3팀 | 김동균 | 349 | C | B+ | D (D/D) | D (D/D) | 79 (79/0) | 60,900 | 600 | 22,995 | 2.6% | 0.0% (0/1) | 37.8% | 6.3% (5/79) | 7 | 97 | 10 | 9 | 25 | 54 |
| 약국3팀 | 박정호 | 352 | C+ | B+ | B+ (S/D) | D (D/D) | 75 (75/0) | 58,100 | 58,100 | 19,138 | 303.6% | 10.7% (8/75) | 32.9% | 10.7% (8/75) | 6 | 93 | 11 | 21 | 25 | 50 |
| 약국3팀 | 이세빈 | 350 | C | A | D (D/D) | D (D/D) | 94 (94/0) | 101,800 | 0 | 28,945 | 0.0% | 0.0% (0/0) | 28.4% | 3.2% (3/94) | 12 | 86 | 13 | 18 | 31 | 63 |
| 약국3팀 | 정찬용 | 350 | C+ | B+ | B+ (S/D) | D (D/D) | 75 (75/0) | 72,800 | 72,800 | 39,645 | 183.6% | 6.7% (5/75) | 54.5% | 6.7% (5/75) | 6 | 92 | 22 | 9 | 25 | 50 |
| 약국4팀 | 김만석 | 385 | C+ | B+ | B+ (S/D) | D (D/D) | 75 (75/0) | 71,700 | 65,900 | 37,072 | 177.8% | 7.2% (5/69) | 51.7% | 8.0% (6/75) | 3 | 82 | 12 | 19 | 0 | 75 |
| 약국4팀 | 박종민 | 373 | C+ | B+ | B+ (S/D) | D (D/D) | 74 (74/0) | 76,200 | 75,000 | 38,072 | 197.0% | 6.8% (5/73) | 50.0% | 6.8% (5/74) | 6 | 75 | 21 | 28 | 25 | 49 |
| 약국4팀 | 지병호 | 379 | C+ | B+ | B+ (S/D) | D (D/D) | 75 (75/0) | 72,300 | 72,300 | 28,932 | 249.9% | 6.7% (5/75) | 40.0% | 6.7% (5/75) | 6 | 73 | 12 | 22 | 26 | 49 |
| 약국4팀 | 최완근 | 378 | C | B+ | C+ (B/D) | D (D/D) | 75 (75/0) | 62,900 | 62,000 | 54,584 | 113.6% | 13.5% (10/74) | 86.8% | 13.3% (10/75) | 8 | 82 | 16 | 10 | 0 | 75 |
| 약국VC1팀 | 김아린 | 595 | C+ | A+ | B+ (S/D) | D (D/D) | 116 (116/0) | 85,000 | 84,800 | 21,412 | 396.0% | 0.9% (1/116) | 25.2% | 0.9% (1/116) | 27 | 91 | 5 | 17 | 38 | 78 |
| 약국VC1팀 | 김영보 | 240 | C+ | S | B+ (S/D) | D (D/D) | 137 (137/0) | 182,500 | 182,300 | 57,441 | 317.4% | 7.3% (10/137) | 31.5% | 5.8% (8/137) | 5 | 35 | 16 | 16 | 46 | 91 |
| 약국VC1팀 | 김영환 | 325 | C | B+ | D (D/D) | D (D/D) | 93 (93/1) | 109,600 | 0 | 47,424 | 0.0% | 0.0% (0/0) | 43.3% | 11.8% (11/93) | 12 | 45 | 23 | 16 | 24 | 69 |
| 약국VC1팀 | 신유림 | 318 | C+ | A+ | B+ (S/D) | D (D/D) | 120 (120/1) | 84,200 | 81,500 | 9,474 | 860.3% | 0.0% (0/119) | 11.3% | 0.0% (0/120) | 16 | 16 | 3 | 9 | 29 | 91 |
| 약국VC1팀 | 황교휘 | 528 | C+ | A+ | B+ (S/D) | D (D/D) | 115 (115/0) | 84,200 | 37,000 | 7,283 | 508.0% | 0.0% (0/37) | 8.6% | 0.0% (0/115) | 21 | 32 | 3 | 4 | 38 | 77 |
| 약국VC2팀 | 강민지 | 282 | C | B+ | D (D/D) | D (D/D) | 79 (79/2) | 81,910 | 0 | 20,414 | 0.0% | 0.0% (0/0) | 24.9% | 5.1% (4/79) | 8 | 18 | 8 | 24 | 14 | 65 |
| 약국VC2팀 | 김민규 | 148 | C | A | D (D/D) | D (D/D) | 94 (94/0) | 434,900 | 0 | 169,504 | 0.0% | 0.0% (0/0) | 39.0% | 6.4% (6/94) | 6 | 24 | 29 | 12 | 31 | 63 |
| 약국VC2팀 | 김재영 | 255 | C | A | D (D/D) | D (D/D) | 94 (94/0) | 70,600 | 0 | 35,512 | 0.0% | 0.0% (0/0) | 50.3% | 11.7% (11/94) | 1 | 8 | 17 | 19 | 31 | 63 |
| 약국VC2팀 | 이송효 | 645 | C | A | C+ (D/B+) | D (D/D) | 94 (94/0) | 68,800 | 9,847 | 13,830 | 71.2% | 73.9% (34/46) | 20.1% | 2.1% (2/94) | 15 | 132 | 11 | 10 | 31 | 63 |
| 약국VC2팀 | 이효섭 | 758 | C | B+ | D (D/D) | D (D/D) | 88 (88/2) | 75,730 | 0 | 9,706 | 0.0% | 0.0% (0/0) | 12.8% | 1.1% (1/88) | 33 | 151 | 2 | 20 | 30 | 58 |
| 약국VC2팀 | 장현우 | 673 | C | A | D (D/D) | D (D/D) | 94 (94/0) | 82,280 | 0 | 13,859 | 0.0% | 0.0% (0/0) | 16.8% | 2.1% (2/94) | 36 | 158 | 8 | 25 | 31 | 63 |
| 약국VC2팀 | 최원호 | 335 | C | B+ | D (D/D) | D (D/D) | 93 (93/0) | 139,000 | 0 | 53,425 | 0.0% | 0.0% (0/0) | 38.4% | 10.8% (10/93) | 4 | 24 | 32 | 11 | 32 | 61 |
| 약국VC3팀 | 김환 | 350 | C+ | A | B+ (S/D) | D (D/D) | 94 (94/0) | 68,800 | 68,500 | 32,429 | 211.2% | 8.5% (8/94) | 47.1% | 8.5% (8/94) | 13 | 111 | 9 | 9 | 31 | 63 |
| 약국VC3팀 | 노종찬 | 355 | C | A | D (D/D) | D (D/D) | 94 (94/0) | 72,200 | 0 | 22,143 | 0.0% | 0.0% (0/0) | 30.7% | 4.3% (4/94) | 45 | 78 | 16 | 11 | 31 | 63 |
| 약국VC3팀 | 박영훈 | 355 | C+ | A | B+ (S/D) | D (D/D) | 94 (94/0) | 98,200 | 97,900 | 48,763 | 200.8% | 7.4% (7/94) | 49.7% | 7.4% (7/94) | 15 | 112 | 14 | 12 | 31 | 63 |
| 약국VC3팀 | 양창주 | 313 | C | A | D (D/D) | D (D/D) | 94 (94/0) | 68,800 | 0 | 32,056 | 0.0% | 0.0% (0/0) | 46.6% | 5.3% (5/94) | 13 | 109 | 13 | 20 | 31 | 63 |
| 약국VC3팀 | 오규하 | 363 | C+ | A | B+ (S/D) | D (D/D) | 94 (94/0) | 106,400 | 103,900 | 47,535 | 218.6% | 12.1% (11/91) | 44.7% | 11.7% (11/94) | 15 | 108 | 15 | 14 | 28 | 66 |
| 약국VC3팀 | 이재일 | 348 | C+ | A | B+ (S/D) | D (D/D) | 94 (94/0) | 78,900 | 78,300 | 45,856 | 170.8% | 10.6% (10/94) | 58.1% | 10.6% (10/94) | 2 | 123 | 18 | 20 | 31 | 63 |
| 약국VC3팀 | 이종민 | 357 | C+ | A | B+ (S/D) | D (D/D) | 94 (94/0) | 90,800 | 90,400 | 41,417 | 218.3% | 7.4% (7/94) | 45.6% | 7.4% (7/94) | 8 | 116 | 12 | 8 | 31 | 63 |
| 약국VC3팀 | 전석진 | 326 | C+ | A | B+ (S/D) | D (D/D) | 94 (94/0) | 68,800 | 68,800 | 36,013 | 191.0% | 7.4% (7/94) | 52.3% | 7.4% (7/94) | 19 | 95 | 20 | 10 | 31 | 63 |
| 약국VC3팀 | 황태근 | 353 | C+ | A | B (A/D) | D (D/D) | 94 (94/0) | 85,800 | 85,800 | 62,092 | 138.2% | 11.7% (11/94) | 72.4% | 11.7% (11/94) | 8 | 118 | 17 | 16 | 31 | 63 |
| 약국VC4팀 | 고진규 | 314 | C+ | A | B+ (S/D) | D (D/D) | 96 (96/0) | 78,600 | 90,000 | 38,138 | 236.0% | 0.0% (0/1) | 48.5% | 7.3% (7/96) | 11 | 95 | 17 | 17 | 30 | 66 |
| 약국VC4팀 | 권삼국 | 311 | C+ | A | B+ (S/D) | D (D/D) | 94 (94/0) | 79,800 | 77,900 | 30,261 | 257.4% | 7.6% (7/92) | 37.9% | 5.3% (5/94) | 13 | 88 | 13 | 9 | 31 | 63 |
| 약국VC4팀 | 김혁 | 313 | C | A | D (D/D) | D (D/D) | 95 (95/0) | 82,900 | 0 | 51,907 | 0.0% | 0.0% (0/0) | 62.6% | 8.4% (8/95) | 17 | 84 | 21 | 16 | 31 | 64 |
| 사무소 | 담당자 | 당위 | 우위 | 동등 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MBO | 약속금액 | 확인금액 | 금액 약속률 | 거래처 약속률 (달성처/약속처) | 금액 일치율 | 거래처 일치율 (달성처/수립처) | MBO | 약속금액 | 확인금액 | 금액 약속률 | 거래처 약속률 (달성처/약속처) | 금액 일치율 | 거래처 일치율 (달성처/수립처) | MBO | 약속금액 | 확인금액 | 금액 약속률 | 거래처 약속률 (달성처/약속처) | 금액 일치율 | 거래처 일치율 (달성처/수립처) | ||
| 약국1팀 | 양지성 | 269,300 | 270,000 | 85,685 | 315.1% | 6.3% (43/685) | 31.8% | 6.3% (43/685) | 265,600 | 266,200 | 106,628 | 249.7% | 4.5% (31/685) | 40.1% | 4.5% (31/685) | 79,400 | 80,100 | 49,733 | 161.1% | 17.2% (40/232) | 62.6% | 17.2% (40/232) |
| 약국2팀 | 이요한 | 161,940 | 89,940 | 37,653 | 238.9% | 3.9% (9/233) | 23.3% | 5.6% (26/461) | 164,420 | 100,620 | 48,041 | 209.4% | 3.0% (7/233) | 29.2% | 5.9% (27/461) | 68,040 | 26,740 | 34,448 | 77.6% | 17.2% (16/93) | 50.6% | 16.3% (40/245) |
| 약국3팀 | 배재현 | 214,100 | 54,700 | 73,393 | 74.5% | 6.0% (9/151) | 34.3% | 7.7% (38/491) | 203,300 | 58,100 | 89,443 | 65.0% | 11.3% (17/151) | 44.0% | 7.9% (39/491) | 90,000 | 18,700 | 43,380 | 43.1% | 20.0% (10/50) | 48.2% | 11.2% (19/169) |
| 약국4팀 | 임태균 | 129,610 | 127,110 | 58,937 | 215.7% | 12.4% (36/291) | 45.5% | 12.4% (37/299) | 141,790 | 136,390 | 75,124 | 181.6% | 8.7% (25/286) | 53.0% | 9.0% (27/299) | 11,700 | 11,700 | 24,599 | 47.6% | 21.6% (11/51) | 210.2% | 21.6% (11/51) |
| 약국VC1팀 | 송하나 | 253,150 | 172,850 | 32,258 | 535.8% | 1.0% (4/394) | 12.7% | 2.1% (12/581) | 228,470 | 162,570 | 86,218 | 188.6% | 9.1% (37/406) | 37.7% | 9.8% (57/581) | 63,880 | 50,180 | 24,557 | 204.3% | 8.1% (12/148) | 38.4% | 8.9% (16/179) |
| 약국VC2팀 | 최재건 | 851,690 | 4,217 | 89,391 | 4.7% | 72.7% (16/22) | 10.5% | 3.0% (19/636) | 69,330 | 4,937 | 181,458 | 2.7% | 66.7% (22/33) | 261.7% | 33.2% (211/636) | 32,200 | 693 | 45,401 | 1.5% | 71.4% (5/7) | 141.0% | 23.0% (46/200) |
| 약국VC3팀 | 김진홍 | 304,300 | 245,600 | 101,571 | 241.8% | 8.5% (56/655) | 33.4% | 7.9% (67/846) | 314,000 | 251,500 | 191,875 | 131.1% | 13.0% (85/653) | 61.1% | 12.1% (102/846) | 120,400 | 96,500 | 74,860 | 128.9% | 21.3% (45/211) | 62.2% | 17.6% (49/278) |
| 약국VC4팀 | 김태환 | 87,100 | 78,400 | 36,246 | 216.3% | 5.4% (5/93) | 41.6% | 8.4% (24/285) | 79,500 | 45,400 | 52,468 | 86.5% | 14.1% (13/92) | 66.0% | 13.7% (39/285) | 74,700 | 44,100 | 31,592 | 139.6% | 14.3% (13/91) | 42.3% | 12.7% (36/284) |
| 사업부 합계 | 김정한 | 2,271,190 | 1,042,817 | 515,134 | 202.4% | 7.1% (178/2524) | 22.7% | 6.2% (266/4284) | 1,466,410 | 1,025,717 | 831,255 | 123.4% | 9.3% (237/2539) | 56.7% | 12.4% (533/4284) | 540,320 | 328,713 | 328,569 | 100.0% | 17.2% (152/883) | 60.8% | 15.7% (257/1638) |
| 사무소 | 담당자 | 당위 | 우위 | 동등 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MBO | 약속금액 | 확인금액 | 금액 약속률 | 거래처 약속률 (달성처/약속처) | 금액 일치율 | 거래처 일치율 (달성처/수립처) | MBO | 약속금액 | 확인금액 | 금액 약속률 | 거래처 약속률 (달성처/약속처) | 금액 일치율 | 거래처 일치율 (달성처/수립처) | MBO | 약속금액 | 확인금액 | 금액 약속률 | 거래처 약속률 (달성처/약속처) | 금액 일치율 | 거래처 일치율 (달성처/수립처) | ||
| 약국1팀 | 권동운 | 49,100 | 49,100 | 29,103 | 168.7% | 15.5% (22/142) | 59.3% | 15.5% (22/142) | 54,900 | 54,900 | 24,540 | 223.7% | 5.6% (8/142) | 44.7% | 5.6% (8/142) | 19,300 | 19,300 | 16,304 | 118.4% | 24.5% (12/49) | 84.5% | 24.5% (12/49) |
| 약국1팀 | 김영수 | 52,000 | 52,000 | 8,112 | 641.0% | 1.4% (2/138) | 15.6% | 1.4% (2/138) | 48,400 | 48,400 | 13,408 | 361.0% | 2.2% (3/138) | 27.7% | 2.2% (3/138) | 20,800 | 20,800 | 9,778 | 212.7% | 15.2% (7/46) | 47.0% | 15.2% (7/46) |
| 약국1팀 | 이규리 | 44,900 | 45,600 | 15,264 | 298.7% | 6.8% (9/133) | 34.0% | 6.8% (9/133) | 44,400 | 45,000 | 23,059 | 195.1% | 6.0% (8/133) | 51.9% | 6.0% (8/133) | 10,700 | 11,400 | 10,498 | 108.6% | 22.7% (10/44) | 98.1% | 22.7% (10/44) |
| 약국1팀 | 이승식 | 42,200 | 42,200 | 13,888 | 303.9% | 2.2% (3/135) | 32.9% | 2.2% (3/135) | 45,100 | 45,100 | 11,372 | 396.6% | 3.0% (4/135) | 25.2% | 3.0% (4/135) | 14,100 | 14,100 | 4,558 | 309.4% | 4.3% (2/47) | 32.3% | 4.3% (2/47) |
| 약국1팀 | 주세훈 | 81,100 | 81,100 | 19,317 | 419.8% | 5.1% (7/137) | 23.8% | 5.1% (7/137) | 72,800 | 72,800 | 34,249 | 212.6% | 5.8% (8/137) | 47.0% | 5.8% (8/137) | 14,500 | 14,500 | 8,594 | 168.7% | 19.6% (9/46) | 59.3% | 19.6% (9/46) |
| 약국2팀 | 김종각 | 0 | 0 | 0 | 0.0% | 0.0% (0/0) | 0.0% | 0.0% (0/0) | 0 | 0 | 0 | 0.0% | 0.0% (0/0) | 0.0% | 0.0% (0/0) | 0 | 0 | 0 | 0.0% | 0.0% (0/0) | 0.0% | 0.0% (0/0) |
| 약국2팀 | 박재만 | 34,800 | 34,800 | 7,572 | 459.6% | 4.3% (5/116) | 21.8% | 4.3% (5/116) | 39,000 | 39,600 | 10,846 | 365.1% | 2.6% (3/116) | 27.8% | 2.6% (3/116) | 11,700 | 11,700 | 9,253 | 126.4% | 17.9% (7/39) | 79.1% | 17.9% (7/39) |
| 약국2팀 | 신천우 | 38,500 | 0 | 7,575 | 0.0% | 0.0% (0/0) | 19.7% | 2.6% (3/115) | 38,300 | 0 | 18,374 | 0.0% | 0.0% (0/0) | 48.0% | 7.0% (8/115) | 14,400 | 0 | 6,719 | 0.0% | 0.0% (0/0) | 46.7% | 10.3% (4/39) |
| 약국2팀 | 안창현 | 39,140 | 39,140 | 8,515 | 459.6% | 3.5% (4/115) | 21.8% | 3.5% (4/115) | 34,020 | 34,020 | 5,741 | 592.6% | 3.5% (4/115) | 16.9% | 3.5% (4/115) | 11,040 | 11,040 | 6,407 | 172.3% | 17.3% (9/52) | 58.0% | 17.3% (9/52) |
| 약국2팀 | 오종현 | 49,500 | 16,000 | 13,991 | 114.4% | 0.0% (0/2) | 28.3% | 12.2% (14/115) | 53,100 | 27,000 | 13,080 | 206.4% | 0.0% (0/2) | 24.6% | 10.4% (12/115) | 30,900 | 4,000 | 12,069 | 33.1% | 0.0% (0/2) | 39.1% | 17.4% (20/115) |
| 약국3팀 | 김기범 | 30,900 | 0 | 11,319 | 0.0% | 0.0% (0/0) | 36.6% | 6.4% (6/94) | 28,200 | 0 | 11,072 | 0.0% | 0.0% (0/0) | 39.3% | 5.3% (5/94) | 12,300 | 0 | 6,400 | 0.0% | 0.0% (0/0) | 52.0% | 9.7% (3/31) |
| 약국3팀 | 김도엽 | 64,400 | 0 | 25,737 | 0.0% | 0.0% (0/0) | 40.0% | 16.2% (12/74) | 51,100 | 0 | 28,870 | 0.0% | 0.0% (0/0) | 56.5% | 12.2% (9/74) | 26,900 | 0 | 12,094 | 0.0% | 0.0% (0/0) | 45.0% | 6.2% (2/32) |
| 약국3팀 | 김동균 | 25,400 | 300 | 7,478 | 4.0% | 0.0% (0/1) | 29.4% | 6.3% (5/79) | 27,200 | 300 | 9,862 | 3.0% | 0.0% (0/1) | 36.3% | 6.3% (5/79) | 8,300 | 0 | 5,654 | 0.0% | 0.0% (0/0) | 68.1% | 16.0% (4/25) |
| 약국3팀 | 박정호 | 24,100 | 24,100 | 5,038 | 478.4% | 6.7% (5/75) | 20.9% | 6.7% (5/75) | 26,500 | 26,500 | 8,947 | 296.2% | 6.7% (5/75) | 33.8% | 6.7% (5/75) | 7,500 | 7,500 | 5,153 | 145.5% | 16.0% (4/25) | 68.7% | 16.0% (4/25) |
| 약국3팀 | 이세빈 | 39,000 | 0 | 14,478 | 0.0% | 0.0% (0/0) | 37.1% | 6.4% (6/94) | 39,000 | 0 | 9,285 | 0.0% | 0.0% (0/0) | 23.8% | 3.2% (3/94) | 23,800 | 0 | 5,183 | 0.0% | 0.0% (0/0) | 21.8% | 0.0% (0/31) |
| 약국3팀 | 정찬용 | 30,300 | 30,300 | 9,342 | 324.3% | 5.3% (4/75) | 30.8% | 5.3% (4/75) | 31,300 | 31,300 | 21,407 | 146.2% | 16.0% (12/75) | 68.4% | 16.0% (12/75) | 11,200 | 11,200 | 8,896 | 125.9% | 24.0% (6/25) | 79.4% | 24.0% (6/25) |
| 약국4팀 | 김만석 | 31,300 | 29,300 | 13,606 | 215.3% | 7.2% (5/69) | 43.5% | 8.0% (6/75) | 40,400 | 36,600 | 16,603 | 220.4% | 4.5% (3/66) | 41.1% | 6.7% (5/75) | 0 | 0 | 6,862 | 0.0% | 0.0% (0/0) | 0.0% | 0.0% (0/0) |
| 약국4팀 | 박종민 | 30,210 | 29,910 | 10,981 | 272.4% | 17.8% (13/73) | 36.4% | 17.6% (13/74) | 37,090 | 36,190 | 22,015 | 164.4% | 7.0% (5/71) | 59.4% | 6.8% (5/74) | 8,900 | 8,900 | 5,075 | 175.4% | 20.0% (5/25) | 57.0% | 20.0% (5/25) |
| 약국4팀 | 지병호 | 45,600 | 45,600 | 10,714 | 425.6% | 8.0% (6/75) | 23.5% | 8.0% (6/75) | 23,900 | 23,900 | 12,717 | 187.9% | 12.0% (9/75) | 53.2% | 12.0% (9/75) | 2,800 | 2,800 | 5,500 | 50.9% | 23.1% (6/26) | 196.4% | 23.1% (6/26) |
| 약국4팀 | 최완근 | 22,500 | 22,300 | 23,636 | 94.3% | 16.2% (12/74) | 105.0% | 16.0% (12/75) | 40,400 | 39,700 | 23,789 | 166.9% | 10.8% (8/74) | 58.9% | 10.7% (8/75) | 0 | 0 | 7,160 | 0.0% | 0.0% (0/0) | 0.0% | 0.0% (0/0) |
| 약국VC1팀 | 김아린 | 32,550 | 32,450 | 6,063 | 535.2% | 1.7% (2/116) | 18.6% | 1.7% (2/116) | 42,270 | 42,170 | 11,619 | 363.0% | 3.4% (4/116) | 27.5% | 3.4% (4/116) | 10,180 | 10,180 | 3,730 | 272.9% | 10.3% (4/39) | 36.6% | 10.3% (4/39) |
| 약국VC1팀 | 김영보 | 97,100 | 88,000 | 6,620 | 1329.3% | 0.8% (1/124) | 6.8% | 0.7% (1/137) | 67,800 | 70,800 | 43,217 | 163.8% | 19.0% (26/137) | 63.7% | 19.0% (26/137) | 17,600 | 23,500 | 7,604 | 309.0% | 13.3% (6/45) | 43.2% | 15.2% (7/46) |
| 약국VC1팀 | 김영환 | 46,600 | 0 | 15,660 | 0.0% | 0.0% (0/0) | 33.6% | 7.5% (7/93) | 44,100 | 0 | 22,337 | 0.0% | 0.0% (0/0) | 50.7% | 21.5% (20/93) | 18,900 | 0 | 9,427 | 0.0% | 0.0% (0/0) | 49.9% | 7.4% (2/27) |
| 약국VC1팀 | 신유림 | 42,400 | 41,300 | 1,624 | 2543.7% | 0.0% (0/117) | 3.8% | 0.0% (0/120) | 36,000 | 34,800 | 5,185 | 671.2% | 4.3% (5/116) | 14.4% | 4.2% (5/120) | 5,800 | 5,400 | 2,665 | 202.6% | 7.4% (2/27) | 46.0% | 10.3% (3/29) |
| 약국VC1팀 | 황교휘 | 34,500 | 11,100 | 2,292 | 484.3% | 2.7% (1/37) | 6.6% | 1.7% (2/115) | 38,300 | 14,800 | 3,862 | 383.3% | 5.4% (2/37) | 10.1% | 1.7% (2/115) | 11,400 | 11,100 | 1,130 | 982.6% | 0.0% (0/37) | 9.9% | 0.0% (0/38) |
| 약국VC2팀 | 강민지 | 78,140 | 0 | 8,695 | 0.0% | 0.0% (0/0) | 11.1% | 2.5% (2/79) | 2,370 | 0 | 8,205 | 0.0% | 0.0% (0/0) | 346.2% | 36.7% (29/79) | 1,400 | 0 | 3,514 | 0.0% | 0.0% (0/0) | 251.0% | 21.4% (3/14) |
| 약국VC2팀 | 김민규 | 428,980 | 0 | 35,079 | 0.0% | 0.0% (0/0) | 8.2% | 1.1% (1/94) | 2,820 | 0 | 115,603 | 0.0% | 0.0% (0/0) | 4099.4% | 59.6% (56/94) | 3,100 | 0 | 18,822 | 0.0% | 0.0% (0/0) | 607.2% | 48.4% (15/31) |
| 약국VC2팀 | 김재영 | 64,320 | 0 | 12,268 | 0.0% | 0.0% (0/0) | 19.1% | 4.3% (4/94) | 3,180 | 0 | 16,272 | 0.0% | 0.0% (0/0) | 511.7% | 42.6% (40/94) | 3,100 | 0 | 6,972 | 0.0% | 0.0% (0/0) | 224.9% | 29.0% (9/31) |
| 약국VC2팀 | 이송효 | 62,610 | 4,217 | 6,527 | 64.6% | 72.7% (16/22) | 10.4% | 2.1% (2/94) | 3,090 | 4,937 | 5,209 | 94.8% | 66.7% (22/33) | 168.6% | 37.2% (35/94) | 3,100 | 693 | 2,094 | 33.1% | 71.4% (5/7) | 67.5% | 9.7% (3/31) |
| 약국VC2팀 | 이효섭 | 41,040 | 0 | 4,007 | 0.0% | 0.0% (0/0) | 9.8% | 2.3% (2/88) | 25,890 | 0 | 3,924 | 0.0% | 0.0% (0/0) | 15.2% | 4.5% (4/88) | 8,800 | 0 | 1,774 | 0.0% | 0.0% (0/0) | 20.2% | 0.0% (0/30) |
| 약국VC2팀 | 장현우 | 75,100 | 0 | 4,022 | 0.0% | 0.0% (0/0) | 5.4% | 0.0% (0/94) | 4,080 | 0 | 5,674 | 0.0% | 0.0% (0/0) | 139.1% | 31.9% (30/94) | 3,100 | 0 | 4,163 | 0.0% | 0.0% (0/0) | 134.3% | 29.0% (9/31) |
| 약국VC2팀 | 최원호 | 101,500 | 0 | 18,792 | 0.0% | 0.0% (0/0) | 18.5% | 8.6% (8/93) | 27,900 | 0 | 26,572 | 0.0% | 0.0% (0/0) | 95.2% | 18.3% (17/93) | 9,600 | 0 | 8,062 | 0.0% | 0.0% (0/0) | 84.0% | 21.9% (7/32) |
| 약국VC3팀 | 김환 | 28,200 | 28,200 | 11,337 | 248.7% | 11.7% (11/94) | 40.2% | 11.7% (11/94) | 31,300 | 31,300 | 13,178 | 237.5% | 8.5% (8/94) | 42.1% | 8.5% (8/94) | 9,300 | 9,000 | 7,914 | 113.7% | 16.7% (5/30) | 85.1% | 16.1% (5/31) |
| 약국VC3팀 | 노종찬 | 29,600 | 0 | 6,563 | 0.0% | 0.0% (0/0) | 22.2% | 4.3% (4/94) | 29,600 | 0 | 11,368 | 0.0% | 0.0% (0/0) | 38.4% | 9.6% (9/94) | 13,000 | 0 | 4,211 | 0.0% | 0.0% (0/0) | 32.4% | 0.0% (0/31) |
| 약국VC3팀 | 박영훈 | 34,600 | 34,600 | 14,731 | 234.9% | 13.8% (13/94) | 42.6% | 13.8% (13/94) | 46,900 | 46,900 | 26,389 | 177.7% | 12.8% (12/94) | 56.3% | 12.8% (12/94) | 16,700 | 16,400 | 7,643 | 214.6% | 13.3% (4/30) | 45.8% | 12.9% (4/31) |
| 약국VC3팀 | 양창주 | 28,200 | 0 | 10,860 | 0.0% | 0.0% (0/0) | 38.5% | 7.4% (7/94) | 31,300 | 0 | 15,951 | 0.0% | 0.0% (0/0) | 51.0% | 8.5% (8/94) | 9,300 | 0 | 5,245 | 0.0% | 0.0% (0/0) | 56.4% | 9.7% (3/31) |
| 약국VC3팀 | 오규하 | 48,700 | 47,800 | 14,487 | 329.9% | 6.6% (6/91) | 29.7% | 6.4% (6/94) | 41,700 | 40,400 | 20,590 | 196.2% | 10.0% (9/90) | 49.4% | 9.6% (9/94) | 16,000 | 15,700 | 12,458 | 126.0% | 20.7% (6/29) | 77.9% | 20.0% (6/30) |
| 약국VC3팀 | 이재일 | 33,900 | 33,900 | 14,322 | 236.7% | 10.6% (10/94) | 42.2% | 10.6% (10/94) | 31,000 | 30,700 | 19,051 | 161.1% | 12.9% (12/93) | 61.5% | 12.8% (12/94) | 14,000 | 13,700 | 12,483 | 109.7% | 30.0% (9/30) | 89.2% | 32.3% (10/31) |
| 약국VC3팀 | 이종민 | 34,000 | 34,000 | 5,472 | 621.3% | 3.2% (3/94) | 16.1% | 3.2% (3/94) | 38,000 | 38,000 | 30,468 | 124.7% | 10.6% (10/94) | 80.2% | 10.6% (10/94) | 18,800 | 18,400 | 5,478 | 335.9% | 6.7% (2/30) | 29.1% | 6.5% (2/31) |
| 약국VC3팀 | 전석진 | 28,200 | 28,200 | 12,465 | 226.2% | 7.4% (7/94) | 44.2% | 7.4% (7/94) | 31,300 | 31,300 | 16,078 | 194.7% | 16.0% (15/94) | 51.4% | 16.0% (15/94) | 9,300 | 9,300 | 7,470 | 124.5% | 22.6% (7/31) | 80.3% | 22.6% (7/31) |
| 약국VC3팀 | 황태근 | 38,900 | 38,900 | 11,333 | 343.3% | 6.4% (6/94) | 29.1% | 6.4% (6/94) | 32,900 | 32,900 | 38,802 | 84.8% | 20.2% (19/94) | 117.9% | 20.2% (19/94) | 14,000 | 14,000 | 11,958 | 117.1% | 38.7% (12/31) | 85.4% | 38.7% (12/31) |
| 약국VC4팀 | 고진규 | 28,300 | 50,000 | 10,498 | 476.3% | 0.0% (0/1) | 37.1% | 12.5% (12/96) | 26,500 | 20,000 | 16,889 | 118.4% | 0.0% (0/1) | 63.7% | 14.6% (14/96) | 23,800 | 20,000 | 10,751 | 186.0% | 0.0% (0/1) | 45.2% | 13.7% (13/95) |
| 약국VC4팀 | 권삼국 | 28,800 | 28,400 | 9,116 | 311.5% | 5.4% (5/92) | 31.7% | 5.3% (5/94) | 26,000 | 25,400 | 12,436 | 204.2% | 14.3% (13/91) | 47.8% | 13.8% (13/94) | 25,000 | 24,100 | 8,708 | 276.7% | 14.4% (13/90) | 34.8% | 14.9% (14/94) |
| 약국VC4팀 | 김혁 | 30,000 | 0 | 16,631 | 0.0% | 0.0% (0/0) | 55.4% | 7.4% (7/95) | 27,000 | 0 | 23,143 | 0.0% | 0.0% (0/0) | 85.7% | 12.6% (12/95) | 25,900 | 0 | 12,133 | 0.0% | 0.0% (0/0) | 46.8% | 9.5% (9/95) |